Selected article for: "International license and th case"
Author: Anita Shet; Debashree Ray; Neelika Malavige; Mathuram Santosham; Naor Bar-Zeev
Title: Differential COVID-19-attributable mortality and BCG vaccine use in countries
  • Document date: 2020_4_6
    • ID: 1n96pz86_9
    Snippet: The median crude COVID-19 mortality per 1 million population among countries with economies classified as low-middle-income, upper-midle-income and high-income countries (LMIC, UMIC, HIC) were 0.4 (Interquartile Range (IQR) 0.06, 0.4), 0.65 (IQR 0.2, 2.2) and 5.5 (IQR 1.6, 13.9), respectively (Fig. 1) . Characteristics of BCG using and non-BCG using countries with respect to the variables considered are shown in supplementary Table S1. In the log.....
    Document: The median crude COVID-19 mortality per 1 million population among countries with economies classified as low-middle-income, upper-midle-income and high-income countries (LMIC, UMIC, HIC) were 0.4 (Interquartile Range (IQR) 0.06, 0.4), 0.65 (IQR 0.2, 2.2) and 5.5 (IQR 1.6, 13.9), respectively (Fig. 1) . Characteristics of BCG using and non-BCG using countries with respect to the variables considered are shown in supplementary Table S1. In the log-linear regression adjusted for per capita GDP, age, and time since 100 th case, COVID-19-attributable mortality among BCG-using countries was 5.8 times lower [95% Confidence . CC-BY-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • BCG country and log linear: 1, 2
    • BCG country and log linear regression: 1, 2
    • BCG country mortality and log linear: 1, 2
    • BCG country mortality and log linear regression: 1, 2
    • cc ND international license and high income: 1
    • cc ND international license and international license: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cc ND international license and log linear: 1, 2, 3
    • cc ND international license and log linear regression: 1
    • cc ND international license and middle income: 1, 2
    • cc ND international license and supplementary Table s1: 1, 2, 3, 4, 5, 6, 7
    • cc ND international license and Table s1: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high income and international license: 1
    • high income and log linear: 1, 2, 3
    • high income and log linear regression: 1, 2, 3
    • high income and median crude: 1
    • high income and median crude mortality: 1
    • high income and middle income: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • high income country and middle income: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • international license and log linear: 1, 2, 3, 4, 5, 6